1. 研究人员发现,在化疗中增加转移方向辐射治疗(MDT)可大大改善寡头转移方向性胰腺癌病人的无进展生存。 1. Researchers found that adding metastasis-directed radiation therapy (MDT) to chemotherapy significantly improves progression-free survival for oligometastatic pancreatic cancer patients.
得克萨斯大学MD Anderson癌症中心的研究人员已经表明,在护理化学治疗标准中增加转移方向辐射治疗,可大大改善寡头转移性胰腺癌患者的无累进生存(PFS)。 Researchers from The University of Texas MD Anderson Cancer Center have shown that adding metastasis-directed radiation therapy (MDT) to standard-of-care chemotherapy significantly improves progression-free survival (PFS) for patients with oligometastatic pancreatic cancer. 在多中心扩展试验中,发现PFS在接受MDT加化疗的病人中为10.3个月,而在接受标准化疗的病人中为2.5个月。 The multicenter EXTEND trial found PFS was 10.3 months in patients who received MDT plus chemotherapy compared to 2.5 months in those who received standard chemotherapy treatment. MDT是一种安全有效的治疗选择,促使第三阶段的扩展试验进一步调查其好处。 MDT is a safe and effective treatment option, prompting a Phase III EXPAND trial to further investigate its benefits.